Methyltransferase Inhibitor

All categories
Name
Methyltransferase Inhibitor
Accession Number
DBCAT005483
Description

Not Available

Drugs
DrugDrug Description
TazemetostatA methyltransferase inhibitor indicated to treat patients 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection.
Drugs & Drug Targets
DrugTargetType
TazemetostatHistone-lysine N-methyltransferase EZH2target
TazemetostatP-glycoprotein 1transporter
TazemetostatMultidrug and toxin extrusion protein 1transporter
TazemetostatMultidrug and toxin extrusion protein 2transporter
TazemetostatCytochrome P450 3A Subfamilyenzyme
TazemetostatHistone-lysine N-methyltransferase EZH1target
TazemetostatATP-binding cassette sub-family G member 2transporter
TazemetostatCytochrome P450 3A4enzyme